CCL20 and neoplasm: The Dong group showed that adoptive transfer of tumor-specific Th17 cells resulted in robust activation of tumor-specific cytotoxic T-cells, and the anti-tumor response elicited was dependent on the Th17 cell-mediated production of CCL20 [75].